A supplement to Family Practice News supported by a restricted grant from TAP Pharmaceutical Products, Inc.
Symposium Highlights of articles based on presentations given at a continuing medical education symposium held on October 22, 2002, in Seattle, Wash.
To view the supplement, click the image above.
INTRODUCTION
A.Mark Fendrick, MD
Associate Professor of Internal Medicine, Health Management & Policy
University of Michigan Medical Center
Ann Arbor, MI
Research Grants: TAP Pharmaceutical Products, Inc., Procter & Gamble Company, Merck & Co., Inc.; Consultant: TAP, AstraZeneca, Procter & Gamble, McNeil-PPC, Inc., Merck; Speaker: TAP.
GERD OFTEN OVERLOOKED IN PEDIATRIC PATIENTS
Harland S. Winter, MD
Director, Pediatric Inflammatory Bowel Disease Center
Massachusetts General Hospital for Children
Harvard Medical School
Boston, MA
Grants: Procter & Gamble, AstraZeneca, TAP, Wyeth, Centocor, Inc., Elan, Con Agra; Research Support: Procter & Gamble, the Anneberg Center; Consultant: AstraZeneca, Wyeth.
PROTON PUMP INHIBITORS REMAIN STANDARD FOR GERD
Richard H. Hunt, FRCP, FRCP(C), FACG
Professor of Medicine
McMaster University Medical Centre
Hamilton, Ont.
Consultant: Abbott Laboratories, Axcan Pharma Inc., AstraZeneca, Merck & Co., Novartis Pharmaceuticals Corp., Procter & Gamble Co., TAP Pharmaceutical Products, Inc.; Investigator: Axcan, AstraZeneca, Merck, TAP.
HEALING AND PREVENTION OF NSAID-ASSOCIATED GASTRIC ULCERS IN ELDERLY PATIENTS
David A. Peura, MD, FACG, FACP
Professor of Medicine
University of Virginia Health Sciences Center
Charlottesville, VA
Speaker: TAP, AstraZeneca, Wyeth, McNeil, Merck.
Copyright © 2002 by International Medical News Group